CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 90 enrolled
Drug / intervention
Panax Notoginseng Saponinsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02999048
NCT02999048Phase 4Completed
CompareCT.gov

Clinical Study on the Treatment of Hypertensive Cerebral Hemorrhage With Panax Notoginseng Saponins

The First People's Hospital of Jingzhou·interventional·Posted Dec 21, 2016·Updated Dec 21, 2016

In Brief

A Phase 4 clinical trial evaluating Panax Notoginseng Saponins for Hematoma Absorption and Neurological Function Recovery. Completed, enrolled 90 participants.

Detailed Summary

The purpose of this study is to determine whether panax notoginseng saponins are effective in the treatment of Hypertensive Intracerebral Hemorrhage Patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHematoma Absorption and Neurological Function Recovery
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 21, 2016
Enrollment StartMay 1, 2014
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 9.5 years ago

Interventions

Panax Notoginseng Saponinsdrug

Panax Notoginseng Saponins integrated with conventional therapy